Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 311.29 |
| Open | 310.10 |
| Bid | 299.29 x 100 |
| Ask | 299.54 x 100 |
| Day's Range | 297.52 - 312.73 |
| 52 Week Range | 211.71 - 329.72 |
| Volume | |
| Avg. Volume | 2,889,031 |
| Market Cap | 160.652B |
| Beta (5Y Monthly) | 0.60 |
| PE Ratio (TTM) | 42.72 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 9.00 (3.00%) |
| Ex-Dividend Date | May 16, 2024 |
| 1y Target Est | N/A |
- Bloomberg
Investors Pile Into Amgen in Search of Next Obesity Drug Payout
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJudge Threatens Trump With Jail Over Gag Order ViolationsTreasury Rally Risks Running Into a $125 Billion Brick WallBuffett Praises Apple After Trimming It, Drops Paramount StakeThe shares s
- Simply Wall St.
Amgen First Quarter 2024 Earnings: EPS Misses Expectations
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
- GuruFocus.com
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.